Randomized Trial of 2 Antibody Induction Steroid Avoidance Protocols
Status:
Completed
Trial end date:
2010-05-01
Target enrollment:
Participant gender:
Summary
The purpose of the present study is to determine which antibody induction regimen will result
in a safer and more effective method to use with steroid avoidance in renal transplant
recipients. Patients receiving either first cadaveric or non-HLA identical living donor
kidney transplants will be preoperatively randomized into 2 groups.
Phase:
Phase 4
Details
Lead Sponsor:
University of Miami
Treatments:
Alemtuzumab Antibodies Antilymphocyte Serum Daclizumab Immunoglobulin G Immunoglobulins Thymoglobulin